Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy-Reference-Cited by-同舟云学术

Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy

Published:1996-07 Issue:3 Volume:13 Page:325-335
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Reddy Sita,Smith Daniel B. J.,Rich Mark M.,Leferovich John M.,Reilly Patricia,Davis Brigid M.,Tran Khoa,Rayburn Helen,Bronson Roderick,Cros Didier,Balice-Gordon Rita J.,Housman David

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng0796-325.pdf

Reference78 articles.

1. Harper, P.S. in Myotonic Dystrophy. 2nd. ed. (W.B. Saunders, 1989).

2. Howeler, C.J., Busch, H.F., Geraedts, J.P., Niermeijer, M.F. & Staal, A. Anticipation in myotonic dystrophy: Fact or fiction?. Brain 112, 779–797 (1989).

3. O'Brien, T., Harper, P.S. Course, prognosis and complications of childhood-onset myotonic dystrophy. Dev. Med. Child. Neurol. 26, 62–67 (1984).

4. Brook, J.D. et al. Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68, 799–808 (1992).

5. Fu, Y.-H. et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255, 1256–1258 (1992).

Cited by 306 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on Therapy for Myotonic Dystrophy Type 1;Current Treatment Options in Neurology;2023-07-14

2. Promising AAV.U7snRNAs vectors targeting DMPK improve DM1 hallmarks in patient-derived cell lines;Frontiers in Cell and Developmental Biology;2023-06-15

3. Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells;Molecular Therapy - Nucleic Acids;2023-06

4. Muscular dystrophy;Neurobiology of Brain Disorders;2023

5. Recent Progress and Challenges in the Development of Antisense Therapies for Myotonic Dystrophy Type 1;International Journal of Molecular Sciences;2022-11-01